143 related articles for article (PubMed ID: 30823625)
1. The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions.
Granda-Díaz R; Menéndez ST; Pedregal Mallo D; Hermida-Prado F; Rodríguez R; Suárez-Fernández L; Vallina A; Sánchez-Canteli M; Rodríguez A; Fernández-García MS; Rodrigo JP; García-Pedrero JM
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30823625
[TBL] [Abstract][Full Text] [Related]
2. SOX2 Expression Is an Independent Predictor of Oral Cancer Progression.
de Vicente JC; Donate-Pérez Del Molino P; Rodrigo JP; Allonca E; Hermida-Prado F; Granda-Díaz R; Rodríguez Santamarta T; García-Pedrero JM
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31640140
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
4. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
5. A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.
Rodrigo JP; Villaronga MÁ; Menéndez ST; Hermida-Prado F; Quer M; Vilaseca I; Allonca E; Pedregal Mallo D; Astudillo A; García-Pedrero JM
Sci Rep; 2017 Sep; 7(1):11110. PubMed ID: 28894270
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
[TBL] [Abstract][Full Text] [Related]
7. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
8. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy.
Rodrigo JP; Álvarez-Alija G; Menéndez ST; Mancebo G; Allonca E; García-Carracedo D; Fresno MF; Suárez C; García-Pedrero JM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1333-41. PubMed ID: 21646305
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.
Villaronga MÁ; Hermida-Prado F; Granda-Díaz R; Menéndez ST; Álvarez-Teijeiro S; Quer M; Vilaseca I; Allonca E; Garzón-Arango M; Sanz-Moreno V; Astudillo A; Rodrigo JP; García-Pedrero JM
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):805-813. PubMed ID: 29654156
[No Abstract] [Full Text] [Related]
10. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.
de Vicente JC; Rodríguez-Santamarta T; Rodrigo JP; Allonca E; Vallina A; Singhania A; Donate-Pérez Del Molino P; García-Pedrero JM
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484317
[TBL] [Abstract][Full Text] [Related]
12. SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.
González-Márquez R; Llorente JL; Rodrigo JP; García-Pedrero JM; Álvarez-Marcos C; Suárez C; Hermsen MA
Hum Pathol; 2014 Apr; 45(4):851-7. PubMed ID: 24656096
[TBL] [Abstract][Full Text] [Related]
13. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
Brustmann H; Brunner A
Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
[TBL] [Abstract][Full Text] [Related]
15. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
[TBL] [Abstract][Full Text] [Related]
16. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
Pedregal-Mallo D; Hermida-Prado F; Granda-Díaz R; Montoro-Jiménez I; Allonca E; Pozo-Agundo E; Álvarez-Fernández M; Álvarez-Marcos C; García-Pedrero JM; Rodrigo JP
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635524
[TBL] [Abstract][Full Text] [Related]
18. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
19. SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma.
Tang XB; Shen XH; Li L; Zhang YF; Chen GQ
Auris Nasus Larynx; 2013 Oct; 40(5):481-6. PubMed ID: 23462687
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
Franchi A; Gallo O; Sardi I; Santucci M
J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
